INNIO
23.6.2022 10:32:13 CEST | Business Wire | Press release
INNIO, a leading energy solution and service provider, has published its Sustainability Report for 2021 Together Towards Zero , which defines the company’s performance in meeting environmental, social, and governance (ESG) goals. While INNIO is currently empowering industries and communities to transition to net zero, this report – prepared in accordance with GRI and SASB standards – formally communicates on progress and sustainability-related performance providing, transparency about how INNIO is contributing to a green tomorrow.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220622005974/en/
Earlier this year, Sustainalytics ranked INNIO number one out more than 500 companies, meaning it has the lowest risk within the machinery industry assessed (Rating of 11 “Low risk level”). In addition, INNIO received the Gold Medal from EcoVadis, placing its Jenbacher business in the top 1% of industry peers. Last year, INNIO became signatory of the Science Based Targets initiative and the United Nations ‘Race to Zero’ campaign, that brings together global leadership for a healthy, resilient, and zero-carbon future.
In accordance with global frameworks and commitments, INNIO set out ambitious sustainability targets in three strategic focus areas where it sees the most material impacts and opportunities for improvement: Low Carbon and Circular Products , Resilient Supply Chain and Manufacturing , and Responsible Operations and Social Responsibility .
Selected key ambitions in these areas include:
- Since 2022, INNIO offers all new engines with a “Ready for H2” option. These models can operate with up to 20% vol. hydrogen1 , and can be retrofitted to 100% H2 operation in the future. All Type 4 series engines are offered for 100% H2 operations. As of 2025 and beyond, the entire Jenbacher product line is expected to be rolled out with 100% hydrogen operation.
- Suppliers covering 80% of direct and indirect spend must commit to net zero by 2050.
- 50% reduction in Scope 1 and Scope 2 GHG emissions in supply chain and manufacturing (vs. the 2020 base) will be fully implemented by 2030.
- By 2025, identified diversity groups will increase by 25% across functions compared to the 2020 baseline. Diverse people leadership will be developed further by 20302 .
Dr. Olaf Berlien, chief executive officer at INNIO, states:
“I’m incredibly proud of the steps we have taken to implement our ESG strategy. The outstanding recognition we have received for our achievements with leading ESG ratings shows that we are on the right track on our path to net zero.”
Marcin Kawa, vice president Sustainability at INNIO, states:
“INNIO’s 2021 Sustainability Report summarizes a year filled with sustainability and ESG initiatives, collaboration, and progress. “This report is the next milestone in our journey as we move ‘Together Towards Zero.’ I’m happy to be part of a team that is so passionate about making a difference while building transparency and trust among our stakeholders worldwide.”
* Rating took place in February 2022
About INNIO’s 2021 Sustainability Report
INNIO’s 2021 Sustainability Report is a non-financial disclosure published annually. This 2021 disclosure was prepared in accordance with the standards of the Global Reporting Initiative (GRI) core option and the Sustainability Accounting Standards Board (SASB). It also includes an initial analysis in line with the Task Force on Climate-related Financial Disclosures (TCFD) Recommendations Framework. The report also serves as Communication on Progress (COP) for the UN Global Compact (UNGC). Through non-financial reporting, INNIO describes its management and performance of environmental, social, and governance (ESG) issues. INNIO’s disclosures focus on the topics that have been deemed most material to the business based on a materiality assessment. INNIO’s alignment with the United Nations Sustainable Development Goals (UN SDGs) is based on the GRI and the UNGC’s Business Reporting on the UN SDGs. This Sustainability Report has been externally assured. The data presented in the report is consolidated at Group level and covers 100% of business operations and 90% of global locations. This boundary applies to all material topics, unless clearly indicated otherwise. All the health, safety, and environmental data, including greenhouse gas (GHG) data for Scope 1, Scope 2, and Scope 3, cover the INNIO Group using the financial control approach.
For more information, access INNIO’s Sustainability Report 2021 here .
About INNIO
INNIO is a leading energy solution and service provider that empowers industries and communities to make sustainable energy work today. With our product brands Jenbacher and Waukesha and our digital platform myPlant, INNIO offers innovative solutions for the power generation and compression segments that help industries and communities generate and manage energy sustainably while navigating the fast-changing landscape of traditional and green energy sources. We are individual in scope, but global in scale. With our flexible, scalable, and resilient energy solutions and services, we are enabling our customers to manage the energy transition along the energy value chain wherever they are in their transition journey.
INNIO is headquartered in Jenbach (Austria), with other primary operations in Waukesha (Wisconsin, U.S.) and Welland (Ontario, Canada). A team of more than 3,500 experts provides life-cycle support to the more than 54,000 delivered engines globally through a service network in more than 80 countries.
INNIO’s ESG Risk Rating places it number one of more than 500 worldwide companies in the Machinery industry assessed by Sustainalytics.
For more information, visit INNIO’s website at www.innio.com . Follow INNIO on Twitter and LinkedIn .
1
Defined in accounting protocol as either sold with the capacity to run on 100% hydrogen or that can be upgraded at a reasonable cost
2
We will focus on distinct employee groups and diversity dimensions (age, gender, nationality, and minorities) when implementing diversity initiatives. For more information, please visit page 78 in our report.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220622005974/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
